The use of eculizumab as a bridge to retransplantation for chronic antibody-mediated rejection in a heart transplant recipient: a case report

BACKGROUND: Antibody-mediated rejection (AMR) remains a major management challenge in heart transplantation given the complexity of pathological diagnosis and dearth of evidence for effective management. Eculizumab, an anti-C5 monoclonal antibody which inhibits terminal complement activation, has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearney, Katherine, Macdonald, Peter, Hayward, Christopher, Muthiah, Kavitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110694/
https://www.ncbi.nlm.nih.gov/pubmed/33997604
http://dx.doi.org/10.1093/ehjcr/ytab180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110694/
https://www.ncbi.nlm.nih.gov/pubmed/33997604
http://dx.doi.org/10.1093/ehjcr/ytab180

Ejemplares similares